9/11 Pancreatic Cancer Lawyers: VCF Compensation & Expedited Claims

Who qualifies for 9/11 pancreatic cancer compensation?

Anyone diagnosed with pancreatic cancer following presence in the covered 9/11 areas, at the Pentagon, or in Shanksville, Pennsylvania during the covered periods may qualify for VCF compensation. This includes area workers, residents, students, teachers, first responders, cleanup and recovery workers, volunteers, and surviving family members of those who died from a 9/11-related pancreatic cancer.

Free medical care runs through the WTC Health Program, which covers Manhattan south of Houston Street and any block in Brooklyn within 1.5 miles of the former World Trade Center site. Compensation runs through the VCF, which covers Manhattan south of Canal Street plus routes of debris removal.

If you were between Canal and Houston Street, you may still qualify for both. Daily life in Lower Manhattan rarely stopped at Canal Street, and presence can be established with records or sworn affidavits.

What types of pancreatic cancer are covered by the WTC Health Program?

The WTC Health Program certifies malignant neoplasms of the pancreas under its rare-cancer framework, covering any cancer occurring in fewer than 15 cases per 100,000 people per year, with a four-year minimum latency.

• Pancreatic adenocarcinoma: the dominant form of pancreatic cancer, accounting for the large majority of cases, and the subtype the VCF treats as presumptively terminal for expedited claims.
• Pancreatic neuroendocrine tumors (PNETs): a less common, biologically distinct subtype. PNETs are certified and compensated on the same terms as adenocarcinoma, but they do not carry the presumptively terminal status described below.

Both subtypes share the same four-year minimum latency and the same $250,000 baseline non-economic loss award.

More than 400,000 people are estimated to have been exposed to 9/11 toxins across the covered areas in New York City, the Pentagon, and Shanksville, Pennsylvania. The dust, smoke, and debris released by the collapse of the World Trade Center contained a mixture of known and suspected carcinogens, and researchers continue to study pancreatic cancer rates among exposed responders and survivors.

Certification does not require identifying one specific chemical as the cause of a particular pancreatic cancer, and it does not require proof that 9/11 exposure was the only cause. Under federal law, the standard is whether the exposure was substantially likely to be a significant factor in aggravating, contributing to, or causing the condition, not whether it was the sole or exclusive cause.

Smoking, chronic pancreatitis, diabetes, and family history are common, independently recognized risk factors for pancreatic cancer. Having one or more of these risk factors does not prevent certification of a 9/11-related pancreatic cancer claim.

Pancreatic cancer often causes few or no symptoms in its early stages, which is why it is frequently diagnosed at an advanced stage. When symptoms appear, they can include:

• Yellowing of the skin or eyes (jaundice), often with dark urine and pale, greasy stools
• Pain in the upper abdomen or back, which may worsen after eating or when lying down
• Unexplained weight loss and loss of appetite
• New-onset diabetes, or a sudden worsening of existing diabetes
• Nausea or vomiting
• Persistent fatigue

Any of these symptoms in a person with 9/11 exposure history should be evaluated promptly by a WTCHP participating specialist. The diagnosis itself can be made by any qualified physician, but certification of the cancer as being 9/11-related is made by the WTCHP.

Pancreatic cancer's minimum latency period is 4 years between first 9/11 exposure and first diagnosis, the standard minimum the WTC Health Program applies to most solid cancers. This latency requirement is set by the WTC Health Program and has no exceptions.

Given that more than two decades have passed since September 11, 2001, nearly every claimant's pancreatic cancer diagnosis, whenever it occurred, satisfies the four-year minimum latency on its own.

By comparison, blood cancers have a minimum latency of just 0.4 years (146 days), thyroid cancer's minimum is 2.5 years, and mesothelioma has the longest latency under the program, at 11 years. Pancreatic cancer falls in the standard four-year group alongside most other solid tumors.

The two-year VCF registration deadline runs from the date the WTC Health Program certifies the pancreatic cancer as 9/11-related, not from the date of diagnosis. Given how quickly pancreatic cancer can progress, registering and requesting expedited processing as early as possible is especially important.

Expedited VCF claims for pancreatic cancer

Pancreatic adenocarcinoma is one of only three conditions the VCF treats as presumptively terminal for expedited claim processing, alongside glioblastoma and acute erythrocytic leukemia. For these three diagnoses, only documentation of the diagnosis itself is required to support an expedite request. No additional medical documentation establishing prognosis or life expectancy is needed, unlike every other condition seeking expedited review.

This presumption does not extend to pancreatic neuroendocrine tumors (PNETs), a biologically distinct and generally slower-growing subtype. A PNET diagnosis can still support an expedited claim, but it requires the same physician documentation of prognosis and life expectancy that other terminal illness expedite requests need.

Expedited status moves a claim ahead in the VCF's review queue. It does not change the award amount, the evidentiary standard, or the offsets applied, and the underlying claim must still be complete with all required presence and exposure documentation. See our full guide to expedited VCF claims for the complete filing process.

What is the VCF payout for 9/11 pancreatic cancer?

Certified 9/11 pancreatic cancer qualifies claimants for free medical treatment through the WTC Health Program, and allows the claimant to submit a claim for financial compensation through the September 11th Victim Compensation Fund. The VCF's non-economic loss award for pancreatic cancer is published in its Non-Economic Loss Awards and Certified Conditions Fact Sheet.

Baseline non-economic loss award

• Pancreatic cancer baseline: $250,000. Pancreatic adenocarcinoma and pancreatic neuroendocrine tumors are compensated at the statutory maximum of $250,000 for a single cancer condition, consistent with the VCF's treatment of solid cancers generally.
• Documentation supporting the baseline. The $250,000 baseline applies with medical documentation of the diagnosis and treatment. Surgery, chemotherapy, radiation, or metastatic spread all support the baseline award, though advanced staging is not required to reach it.

Aggregate compensation, economic loss, and wrongful death

Non-economic loss compensation for a single cancer condition is capped at $250,000 under the VCF Act. For a claimant with two or more certified cancers, aggregate non-economic loss compensation generally reaches at least $300,000, and the current VCF aggregate maximum of $340,000 is reserved for claims involving multiple certified cancers or a certified cancer alongside another certified condition of extraordinary severity.

In addition to non-economic loss, the VCF may award economic loss for medical expenses and lost earnings. Wrongful death compensation is available to the personal representatives of individuals who died from a 9/11-related pancreatic cancer, and it can also be requested on an expedited basis. Attorney fees for VCF claims are capped at 10% by federal statute.

How Baione Law handles a 9/11 pancreatic cancer claim

Baione Law represents 9/11 pancreatic cancer claimants at every stage, and moves quickly given how fast this disease can progress:

1. Free Case Review. The firm evaluates presence in the exposure zone, exposure category, pancreatic cancer diagnosis, subtype, and current WTCHP certification status. No cost, no obligation.
2. WTC Health Program enrollment and certification support. For claimants not yet enrolled, the firm assists with enrollment and coordinates medical record submission to WTCHP providers for certification.
3. VCF registration, expedited request, and claim filing. The firm registers the claim, submits the expedited processing request, files the compensation claim, and prepares supporting documentation.
4. Medical records and impact documentation. The firm compiles the medical, economic, and non-economic loss documentation the VCF requires.
5. Award, appeals, and amendments. After the VCF issues an award, the firm reviews it, files an appeal if warranted, and handles amendments or wrongful death conversion as needed.

Attorney fees are capped at 10% by federal statute.